Ilia I. Ouspenski

Array ( [id] => 7226862 [patent_doc_number] => 20040073012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Antibodies specific for a cell surface molecule mediating cell adhesion and signal transmission, cells secreting such antibodies, and methods of making and using such antibodies' [patent_app_type] => new [patent_app_number] => 10/704426 [patent_app_country] => US [patent_app_date] => 2003-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 31646 [patent_no_of_claims] => 155 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20040073012.pdf [firstpage_image] =>[orig_patent_app_number] => 10704426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7675742 [patent_doc_number] => 20040126376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Tumour necrosis factor binding ligands' [patent_app_type] => new [patent_app_number] => 10/702681 [patent_app_country] => US [patent_app_date] => 2003-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 13688 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0126/20040126376.pdf [firstpage_image] =>[orig_patent_app_number] => 10702681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7083192 [patent_doc_number] => 20050048572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Methods and compositions for increasing antibody production' [patent_app_type] => utility [patent_app_number] => 10/697995 [patent_app_country] => US [patent_app_date] => 2003-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 37432 [patent_no_of_claims] => 120 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20050048572.pdf [firstpage_image] =>[orig_patent_app_number] => 10697995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 203010 [patent_doc_number] => 07632935 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-15 [patent_title] => 'DNA encoding a mast cell-derived membrane protein' [patent_app_type] => utility [patent_app_number] => 10/531973 [patent_app_country] => US [patent_app_date] => 2003-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14787 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/632/07632935.pdf [firstpage_image] =>[orig_patent_app_number] => 10531973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4938393 [patent_doc_number] => 20080075712 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'Double Specific Antibodies Substituting For Functional Proteins' [patent_app_type] => utility [patent_app_number] => 10/575905 [patent_app_country] => US [patent_app_date] => 2003-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 21289 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20080075712.pdf [firstpage_image] =>[orig_patent_app_number] => 10575905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 602588 [patent_doc_number] => 07432351 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-10-07 [patent_title] => 'B7-H1 variants' [patent_app_type] => utility [patent_app_number] => 10/679775 [patent_app_country] => US [patent_app_date] => 2003-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 13695 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/432/07432351.pdf [firstpage_image] =>[orig_patent_app_number] => 10679775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 400968 [patent_doc_number] => 07291331 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-11-06 [patent_title] => 'Methods of treating OX40 medicated recall immune responses' [patent_app_type] => utility [patent_app_number] => 10/661358 [patent_app_country] => US [patent_app_date] => 2003-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16578 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/291/07291331.pdf [firstpage_image] =>[orig_patent_app_number] => 10661358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7677721 [patent_doc_number] => 20040152105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Immune modulatory compounds and methods' [patent_app_type] => new [patent_app_number] => 10/656269 [patent_app_country] => US [patent_app_date] => 2003-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 28619 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152105.pdf [firstpage_image] =>[orig_patent_app_number] => 10656269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 382848 [patent_doc_number] => 07306800 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-11 [patent_title] => 'Treatment of autoimmune disorders with antibodies to costimulating polypeptide of T cells' [patent_app_type] => utility [patent_app_number] => 10/647072 [patent_app_country] => US [patent_app_date] => 2003-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 7456 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/306/07306800.pdf [firstpage_image] =>[orig_patent_app_number] => 10647072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 602299 [patent_doc_number] => 07432062 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-07 [patent_title] => 'Screening methods using B7-H2 molecules, members of the B7 family' [patent_app_type] => utility [patent_app_number] => 10/644671 [patent_app_country] => US [patent_app_date] => 2003-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 48 [patent_no_of_words] => 35768 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/432/07432062.pdf [firstpage_image] =>[orig_patent_app_number] => 10644671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7674660 [patent_doc_number] => 20040127458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Beta-glucan containing compositions, methods for manufacturing beta-glucans, and for manufacturing and using beta-glucans and conjugates thereof as vaccine adjuvants' [patent_app_type] => new [patent_app_number] => 10/630143 [patent_app_country] => US [patent_app_date] => 2003-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12867 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127458.pdf [firstpage_image] =>[orig_patent_app_number] => 10630143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 539215 [patent_doc_number] => 07166283 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-23 [patent_title] => 'Methods of treating an inflammatory disorder and prohibiting proliferation, cytokine production, and signal transduction with antibody against costimulatory signal transduction molecule AILIM' [patent_app_type] => utility [patent_app_number] => 10/625105 [patent_app_country] => US [patent_app_date] => 2003-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 78 [patent_figures_cnt] => 89 [patent_no_of_words] => 47863 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/166/07166283.pdf [firstpage_image] =>[orig_patent_app_number] => 10625105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5872891 [patent_doc_number] => 20060165675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Modulation of mesenchymal cells via iga-receptors' [patent_app_type] => utility [patent_app_number] => 10/520284 [patent_app_country] => US [patent_app_date] => 2003-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 18540 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20060165675.pdf [firstpage_image] =>[orig_patent_app_number] => 10520284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7288616 [patent_doc_number] => 20040109847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Treatment and prophylaxis with 4-1BB-binding agents' [patent_app_type] => new [patent_app_number] => 10/619824 [patent_app_country] => US [patent_app_date] => 2003-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12137 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20040109847.pdf [firstpage_image] =>[orig_patent_app_number] => 10619824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 236068 [patent_doc_number] => 07595048 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-29 [patent_title] => 'Method for treatment of cancer by inhibiting the immunosuppressive signal induced by PD-1' [patent_app_type] => utility [patent_app_number] => 10/519925 [patent_app_country] => US [patent_app_date] => 2003-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 32 [patent_no_of_words] => 13792 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/595/07595048.pdf [firstpage_image] =>[orig_patent_app_number] => 10519925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7419065 [patent_doc_number] => 20040228858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Human monoclonal antibodies to CTLA-4' [patent_app_type] => new [patent_app_number] => 10/612497 [patent_app_country] => US [patent_app_date] => 2003-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 32398 [patent_no_of_claims] => 104 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20040228858.pdf [firstpage_image] =>[orig_patent_app_number] => 10612497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7675337 [patent_doc_number] => 20040126781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Methods of preventing immune-mediated abortion by inhibiting a CD28-mediated costimulatory signal' [patent_app_type] => new [patent_app_number] => 10/609218 [patent_app_country] => US [patent_app_date] => 2003-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 23075 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0126/20040126781.pdf [firstpage_image] =>[orig_patent_app_number] => 10609218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7362636 [patent_doc_number] => 20040005321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Use of anti-ceacam antibodies for stimulating b cells in the production of monoclonal antibodies or in immunotheraphy' [patent_app_type] => new [patent_app_number] => 10/344036 [patent_app_country] => US [patent_app_date] => 2003-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6251 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20040005321.pdf [firstpage_image] =>[orig_patent_app_number] => 10344036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7402445 [patent_doc_number] => 20040175380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Compositions and methods for modulating lymphocyte activity' [patent_app_type] => new [patent_app_number] => 10/600997 [patent_app_country] => US [patent_app_date] => 2003-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 36733 [patent_no_of_claims] => 87 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20040175380.pdf [firstpage_image] =>[orig_patent_app_number] => 10600997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6634979 [patent_doc_number] => 20030211582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Human DNA Ligase III' [patent_app_type] => new [patent_app_number] => 10/464768 [patent_app_country] => US [patent_app_date] => 2003-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13470 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211582.pdf [firstpage_image] =>[orig_patent_app_number] => 10464768 [rel_patent_id] =>[rel_patent_doc_number] =>)